Alto Neuroscience, Inc.
NYSE:ANROBiotechnology
Healthcare
$25.91 +1.84%
+$0.40 today
- Market cap
- $1.04B
- Beta
- 1.25
- P/E (TTM)
- -9.8
- EPS (TTM)
- -$2.26
52W Low $2.15High $28.44
Volume 0.99M
Average 0.34M
Price history
Alto Neuroscience, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+66.73%
Period high
$36.64
Period low
$12.80
Latest
$25.91
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 10, 2026 | Nov 10, 2026 | |
| 8-K | Nov 10, 2026 | Nov 10, 2026 | |
| SC 13G | Oct 30, 2026 | Oct 30, 2026 | |
| 4 | Oct 5, 2026 | Oct 5, 2026 | |
| 4 | Oct 1, 2026 | Oct 1, 2026 | |
| 8-K | Aug 27, 2026 | Aug 27, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| 10-Q | Aug 12, 2026 | Aug 12, 2026 | |
| 8-K | Aug 12, 2026 | Aug 12, 2026 | |
| SC 13G | Jul 27, 2026 | Jul 27, 2026 | |
| SC 13G | Jul 20, 2026 | Jul 20, 2026 | |
| 8-K | Jul 14, 2026 | Jul 14, 2026 | |
| 424B5 | Jul 14, 2026 | Jul 14, 2026 |
Competitors
Who does Alto Neuroscience, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about ANRO's filings, answered from its disclosures.
What is the latest ANRO filing?
The latest filing shown is 10-Q dated Nov 10, 2026.
How many recent filings does ANRO have?
Intrinsic Alpha currently shows 20 recent filings for ANRO.
Continue the stock analysis
Jump to another research area for this company.